Ferumoxytol is an ultrasmall superparamagnetic iron oxide agent marketed for the treatment of anemia. There has been increasing interest in its properties as an MRI contrast agent as well as greater awareness of its adverse event profile. This mini-review summarizes the current state of knowledge of the risks of ferumoxytol and methods of administration. Magn Reson Med 75:2107-2111, 2016. © 2016 Wiley Periodicals, Inc.
View details for DOI 10.1002/mrm.26151
View details for PubMedID 26890830
View details for PubMedCentralID PMC4854636